CG
GOSS icon

Caprock Group’s Gossamer Bio GOSS Stock Holding History

Caprock Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5K Hold
70,000
– – ﹤0.01% 1232
2026
Q1 		$23K Sell
70,000
-10,000
-13% -$15.7K ﹤0.01% 1107
2025
Q4 		$248K Buy
+80,000
New +$228K 0.01% 1050

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Caprock Group's GOSS Position: Q2 2026 in Review

Caprock Group held its Gossamer Bio (GOSS) position steady in Q2 2026 at 70,000 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1232.

Caprock Group first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $248K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Caprock Group held 70,000 shares of Gossamer Bio worth $11.5K as of Q2 2026.
  • Caprock Group left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1232 holding.
  • Caprock Group first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Caprock Group's Gossamer Bio position peaked at $248K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.